1420 TANSHINONE IIA INHIBITS ESTROGEN/ANDROGEN INDUCED PROSTATIC STROMAL HYPERPLASIA
Rui Yang,Da Xu,Jiandang Shi,Helmut Klocker,Chung Lee,Ju Zhang
DOI: https://doi.org/10.1016/j.juro.2010.02.1112
2010-01-01
Abstract:You have accessJournal of UrologyBenign Prostatic Hyperplasia: Basic Research1 Apr 20101420 TANSHINONE IIA INHIBITS ESTROGEN/ANDROGEN INDUCED PROSTATIC STROMAL HYPERPLASIA Rui Yang, Da Xu, Jiandang Shi, Helmut Klocker, Chung Lee, and Ju Zhang Rui YangRui Yang Tianjin, People's Republic of China More articles by this author , Da XuDa Xu Tianjin, People's Republic of China More articles by this author , Jiandang ShiJiandang Shi Tianjin, People's Republic of China More articles by this author , Helmut KlockerHelmut Klocker Innsbruck, Austria More articles by this author , Chung LeeChung Lee Chicago, IL More articles by this author , and Ju ZhangJu Zhang Tianjin, People's Republic of China More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1112AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Stromal smooth muscle cells (SMCs) play an important role in the pathogenesis and clinical symptom of benign prostatic hyperplasia (BPH) and estrogen are considered critical regulators in this disease. While evidences showed that some phytoestrogens extracted from the Chinese herbal medicines have an inhibitory effect on the proliferation of vascular smooth muscle cells, few studies have reported their effects on prostatic stromal cells. METHODS The human prostatic stromal cell line WPMY-1 was used to study the effect of different phytoestrogens including tanshinone IIA, genistein, puerarin, psoralen and icraiin. After exposure for 48hrs, cells were counted and MTT assays performed. Relatively efficacious phytoestrogens were further tested in vivo in an estrogen/androgen induced rat BPH model to validate the suppressive effect on prostatic stromal hyperplasia. Cell cycle analysis and the expression of cell cycle related genes in WPMY-1 cells were detected by flow cytometry and real-time PCR, respectively. RESULTS Among the 5 phytoestrogens tested, puerarin and especially tanshinone IIA inhibited the proliferation of WPMY-1 cells in a time- and dose-dependent manner. In the rat BPH model, the glandular acini were surrounded by multiple layers of stromal cells, and the SMC layer was much thicker than in the non-induced control group (p<0.01). Treatment with tanshinone IIA effectively decreased the thickness of SMC layers; at some doses of this drug the layers were as thin as in the non-induced group. There was no manifest change of the number of gland lumen, which reveals that this phytoestrogen therapy do not induce significant epithelial hyperplasia. Cell cycle analysis in WPMY-1 cells revealed inhibition of proliferation by tanshinone IIA via G2/M phase arrest and dramatically decreased expression of CyclinB1. CONCLUSIONS Tanshinone IIA can significantly inhibit the proliferation of prostatic stromal cells by G2/M cell cycle arrest, and can suppress the pathogenic changes in a rat model of prostatic stromal hyperplasia. These results support tanshinone IIA as an effective and safe agent for treating prostatic hyperplasia. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e547-e548 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Rui Yang Tianjin, People's Republic of China More articles by this author Da Xu Tianjin, People's Republic of China More articles by this author Jiandang Shi Tianjin, People's Republic of China More articles by this author Helmut Klocker Innsbruck, Austria More articles by this author Chung Lee Chicago, IL More articles by this author Ju Zhang Tianjin, People's Republic of China More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...